Vitamin D and the risk of acute allograft rejection following human liver transplantation

Liver International

Volumn 30, Issue 3, 2010, Pages 417-44

  Bitetto, Davide ^a   Fabris, Carlo ^a   Falleti, Edmondo ^a   Fornasiere, Ezio ^a   Fumolo, Elisa ^a   Fontanini, Elisabetta ^a   Cussigh, Annarosa ^a   Occhino, Giuseppa ^b   Baccarani, Umberto ^a   Pirisi, Mario ^b   Toniutto, Pierluigi ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Acute cellular rejection; Cholecalciferol; Liver transplantation

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; CORTICOSTEROID; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISONE; TACROLIMUS; VITAMIN D;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRETEST POSTTEST DESIGN; RISK ASSESSMENT; TREATMENT RESPONSE; VIRUS REACTIVATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 77950598712     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02154.x     Document Type: Article

References (33)

1. Fisher LR, Henley KS, Lucey MR. Acute cellular rejection after liver transplantation: variability, morbidity, and mortality. Liver Transpl Surg 1995, 1:10-5.
2. Demetris AJ, Ruppert K, Dvorchik I. Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation 2002, 74:1290-6.
3. Dousset B, Conti F, Cherruau B. Is acute rejection deleterious to long-term liver allograft function? J Hepatol 1998, 29:660-8.
4. Geissler EK, Schlitt HJ. Immunosuppression for liver transplantation. Gut 2009, 58:452-63.
5. Farkas SA, Schnitzbauer AA, Kirchner G. Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int 2009, 22:49-60.
6. Wiesner RH, Demetris AJ, Belle SH. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998, 28:638-45.
7. Bathgate AJ, Hynd P, Sommerville D, Hayes PC. The prediction of acute cellular rejection in orthotopic liver transplantation. Liver Transpl Surg 1999, 5:475-9.
8. Gomez-Mateo J, Marin L, Lopez-Alvarez MR. TGF-beta1 gene polymorphism in liver graft recipients. Transpl Immunol 2006, 17:55-7.
9. Tanaci N, Karakose H, Guvener N. Influence of 1,25-dihydroxyvitamin D3 as an immunomodulator in renal transplant recipients: a retrospective cohort study. Transpl Proc 2003, 35:2885-7.
10. Briffa NK, Keogh AM, Sambrook PN, Eisman JA. Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol. Transplantation 2003, 75:2133-4.
11. Redaelli CA, Wagner M, Tien YH. 1 alpha,25-dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts. Hepatology 2001, 34:926-34.
12. Assessment of vitamin D status. Update on Vitamin D. Position Statement by the Scientific Advisory Committee on Nutrition 2007, 7-9. Scientific Advisory Committee on Nutrition., In, The Stationery Office, ed., London, The Stationery Office
13. Demetrius AJ, Batts KP, Dhillon AP. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997, 25:658-63.
14. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006, 116:2062-72.
15. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009, 19:73-8.
16. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80:1689S-96S.
17. Christakos S, Dhawan P, Benn B. Vitamin D: molecular mechanism of action. Ann N Y Acad Sci 2007, 1116:340-8.
18. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006, 92:4-8.
19. Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357:266-81.
20. Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr 1985, 42:644-9.
21. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007, 5:513-20.
22. Zittermann A, Schleithoff SS, Gotting C. Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation 2009, 87:118-24.
23. Chun RF, Adams JS, Hewison M. Back to the future: a new look at 'old' vitamin D. J Endocrinol 2008, 198:261-9.
24. Cavalier E, Delanaye P, Chapelle JP, Souberbielle JC. Vitamin D: current status and perspectives. Clin Chem Lab Med 2009, 47:120-7.
25. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008, 4:80-90.
26. White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun 2008, 76:3837-43.
27. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005, 97:93-101.
28. Adams JS, Liu PT, Chun R, Modlin RL, Hewison M. Vitamin D in defense of the human immune response. Ann N Y Acad Sci 2007, 1117:94-105.
29. Becker BN, Hullett DA, O'Herrin JK. Vitamin D as immunomodulatory therapy for kidney transplantation. Transplantation 2002, 74:1204-6.
30. Zhang AB, Zheng SS, Jia CK, Wang Y. Effect of 1,25-dihydroxyvitamin D3 on preventing allograft from acute rejection following rat orthotopic liver transplantation. World J Gastroenterol 2003, 9:1067-71.
31. Lindor KD. Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis. Semin Liver Dis 1993, 13:367-73.
32. Szodoray P, Nakken B, Gaal J. The complex role of vitamin D in autoimmune diseases. Scand J Immunol 2008, 68:261-9.
33. Cantorna MT, Yu S, Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med 2008, 29:369-75.